The enigma of atypical femoral fractures: a summary of current knowledge
Objective:
to give an overview on definition,
pathogenesis, epidemiology, diagnosis, and state of- the-art treatment of atypical femoral fractures, mainly following the long-term use of bisphosphonates.
Comment on results:
The diagnosis follows major and minor criteria, which were originally described by the Task Force of the ASBMR. The risk of suffering a fracture is very low, even after long term use of bisphosphonate, but the diagnosis should lead to discontinuation

